IGC Pharma, Inc. — Director's Dealing 2014

Nov 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2014-10-16

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-04	Common stock	G	1500	—	Disposed	96000	Direct
2014-04-11	Common stock	G	1500	—	Disposed	94500	Direct
2014-04-17	Common stock	G	1500	—	Disposed	93000	Direct
2014-04-25	Common stock	G	1500	—	Disposed	91500	Direct
2014-05-02	Common stock	G	1500	—	Disposed	90000	Direct
2014-05-09	Common stock	G	1500	—	Disposed	88500	Direct
2014-05-16	Common stock	G	1500	—	Disposed	87000	Direct
2014-05-23	Common stock	G	8000	—	Disposed	79000	Direct
2014-05-30	Common stock	G	1000	—	Disposed	78000	Direct
2014-06-06	Common stock	G	1000	—	Disposed	77000	Direct
2014-06-13	Common stock	G	1000	—	Disposed	76000	Direct
2014-06-20	Common stock	G	1000	—	Disposed	75000	Direct
2014-06-27	Common stock	G	1000	—	Disposed	74000	Direct
2014-07-03	Common stock	G	1000	—	Disposed	73000	Direct
2014-07-11	Common stock	G	1000	—	Disposed	72000	Direct
2014-07-18	Common stock	G	1000	—	Disposed	71000	Direct
2014-07-25	Common stock	G	1000	—	Disposed	70000	Direct
2014-08-01	Common stock	G	1000	—	Disposed	69000	Direct
2014-08-08	Common stock	G	1000	—	Disposed	68000	Direct
2014-08-15	Common stock	G	1000	—	Disposed	67000	Direct
2014-08-22	Common stock	G	1000	—	Disposed	66000	Direct
2014-08-29	Common stock	G	1000	—	Disposed	65000	Direct
2014-09-08	Common stock	G	1000	—	Disposed	64000	Direct
2014-09-12	Common stock	G	1000	—	Disposed	63000	Direct
2014-09-19	Common stock	G	1000	—	Disposed	62000	Direct
2014-09-26	Common stock	G	1000	—	Disposed	61000	Direct
2014-10-03	Common stock	G	1000	—	Disposed	60000	Direct
2014-10-16	Common stock	A	250000	—	Acquired	308000	Direct
2014-10-16	Common stock	A	50000	—	Acquired	358000	Direct
2014-10-27	Common stock	G	1000	—	Disposed	59000	Direct

Footnotes

F1: Represents shares of Restricted Stock awarded pursuant to a special grant approved by the Issuer's shareholders at the 2014 Annual Meeting of Stockholders. The shares vest upon certain performance metrics being achieved.

F2: Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.